Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling

References

• Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–e528.30700139
   PubMed Web of Science ®Google Scholar
• Aghaei M, Motallebnezhad M, Ghorghanlu S, et al. Targeting autophagy in cardiac ischemia/reperfusion injury: a novel therapeutic strategy. J Cell Physiol. 2019. doi:10.1002/jcp.28345
   Web of Science ®Google Scholar
• Li D, Wang X, Huang Q, Li S, Zhou Y, Li Z. Cardioprotection of CAPE-oNO2 against myocardial ischemia/reperfusion induced ROS generation via regulating the SIRT1/eNOS/NF-kappaB pathway in vivo and in vitro. Redox Biol. 2017;15:62–73. doi:10.1016/j.redox.2017.11.02329220696
   PubMed Web of Science ®Google Scholar
• Scoote M, Williams AJ. The cardiac ryanodine receptor (calcium release channel): emerging role in heart failure and arrhythmia pathogenesis. Cardiovasc Res. 2002;56(3):359–372. doi:10.1016/s0008-6363(02)00574-612445877
   PubMed Web of Science ®Google Scholar
• Li J, Xiang X, Gong X, Shi Y, Yang J, Xu Z. Cilostazol protects mice against myocardium ischemic/reperfusion injury by activating a PPARgamma/JAK2/STAT3 pathway. Biomed Pharmacother. 2017;94:995–1001. doi:10.1016/j.biopha.2017.07.14328810537
   PubMed Web of Science ®Google Scholar
• Xie XJ, Fan DM, Xi K, et al. Suppression of microRNA-135b-5p protects against myocardial ischemia/reperfusion injury by activating JAK2/STAT3 signaling pathway in mice during sevoflurane anesthesia. Biosci Rep. 2017;37(3). doi:10.1042/BSR20170186
   Web of Science ®Google Scholar
• Toldo S, Marchetti C, Mauro AG, et al. Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse. Int J Cardiol. 2016;209:215–220. doi:10.1016/j.ijcard.2016.02.04326896627
   PubMed Web of Science ®Google Scholar
• Mattiazzi A, Argenziano M, Aguilar-Sanchez Y, Mazzocchi G, Escobar AL. Ca2+ Sparks and Ca2+ waves are the subcellular events underlying Ca2+ overload during ischemia and reperfusion in perfused intact hearts. J Mol Cell Cardiol. 2015;79:69–78. doi:10.1016/j.yjmcc.2014.10.01125451173
   PubMed Web of Science ®Google Scholar
• Di Carlo MN, Said M, Ling H, et al. CaMKII-dependent phosphorylation of cardiac ryanodine receptors regulates cell death in cardiac ischemia/reperfusion injury. J Mol Cell Cardiol. 2014;74:274–283. doi:10.1016/j.yjmcc.2014.06.00424949568
   PubMed Web of Science ®Google Scholar
• Garcia-Dorado D, Ruiz-Meana M, Inserte J, Rodriguez-Sinovas A, Piper HM. Calcium-mediated cell death during myocardial reperfusion. Cardiovasc Res. 2012;94(2):168–180. doi:10.1093/cvr/cvs11622499772
   PubMed Web of Science ®Google Scholar
• Gerlach AT, Murphy CV, Dasta JF. An updated focused review of dexmedetomidine in adults. Ann Pharmacother. 2009;43(12):2064–2074. doi:10.1345/aph.1M31019934395
   PubMed Web of Science ®Google Scholar
• Sun Z, Zhao T, Lv S, Gao Y, Masters J, Weng H. Dexmedetomidine attenuates spinal cord ischemia-reperfusion injury through both anti-inflammation and anti-apoptosis mechanisms in rabbits. J Transl Med. 2018;16(1):209. doi:10.1186/s12967-018-1583-730031397
   PubMed Web of Science ®Google Scholar
• Yang Y, Duan W, Jin Z, et al. JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury. J Pineal Res. 2013;55(3):275–286. doi:10.1111/jpi.1207023796350
   PubMed Web of Science ®Google Scholar
• Ji F, Li Z, Young N, Moore P, Liu H. Perioperative dexmedetomidine improves mortality in patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2014;28(2):267–273. doi:10.1053/j.jvca.2013.06.02224182835
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Peng K, Zhang J, Meng XW, Ji FH. Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-small ka, CyrillicB signaling pathway. PLoS One. 2017;12(2):e0172006. doi:10.1371/journal.pone.017200628222157
   PubMed Web of Science ®Google Scholar
• Takizuka A, Minami K, Uezono Y, et al. Dexmedetomidine inhibits muscarinic type 3 receptors expressed in Xenopus oocytes and muscarine-induced intracellular Ca2+ elevation in cultured rat dorsal root ganglia cells. Naunyn Schmiedebergs Arch Pharmacol. 2007;375(5):293–301. doi:10.1007/s00210-007-0168-417563882
   PubMed Web of Science ®Google Scholar
• Xiao YF, Zeng ZX, Guan XH, et al. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca(2+)/calmodulin-mediated signalling pathways in vivo and in vitro. J Cell Mol Med. 2018;22(7):3638–3651. doi:10.1111/jcmm.1364529682889
   PubMed Web of Science ®Google Scholar
• Zhang X, Tallini YN, Chen Z, et al. Dissociation of FKBP12.6 from ryanodine receptor type 2 is regulated by cyclic ADP-ribose but not beta-adrenergic stimulation in mouse cardiomyocytes. Cardiovasc Res. 2009;84(2):253–262. doi:10.1093/cvr/cvp21219578067
   PubMed Web of Science ®Google Scholar
• He H, Shi M, Zeng X, et al. Decreased FKBP12.6 expression and enhanced endothelin receptor signaling associated with arrhymogenesis in myocardial infarction rats. Phytother Res. 2008;22(8):1115–1124. doi:10.1002/ptr.247018570278
   PubMed Web of Science ®Google Scholar
• Fauconnier J, Roberge S, Saint N, Lacampagne A. Type 2 ryanodine receptor: a novel therapeutic target in myocardial ischemia/reperfusion. Pharmacol Ther. 2013;138(3):323–332. doi:10.1016/j.pharmthera.2013.01.01523384595
   PubMed Web of Science ®Google Scholar
• Ling H, Gray CB, Zambon AC, et al. Ca2+/Calmodulin-dependent protein kinase II delta mediates myocardial ischemia/reperfusion injury through nuclear factor-kappaB. Circ Res. 2013;112(6):935–944. doi:10.1161/CIRCRESAHA.112.27691523388157
   PubMed Web of Science ®Google Scholar
• Chelu MG, Sarma S, Sood S, et al. Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. J Clin Invest. 2009;119(7):1940–1951. doi:10.1172/jci3705919603549
   PubMed Web of Science ®Google Scholar
• Yin B, Hou XW, Lu ML. Astragaloside IV attenuates myocardial ischemia/reperfusion injury in rats via inhibition of calcium-sensing receptor-mediated apoptotic signaling pathways. Acta Pharmacol Sin. 2018;40(5):599–607. doi:10.1038/s41401-018-0082-y30030530
   PubMed Web of Science ®Google Scholar
• Meng Y, Li WZ, Shi YW, Zhou BF, Ma R, Li WP. Danshensu protects against ischemia/reperfusion injury and inhibits the apoptosis of H9c2 cells by reducing the calcium overload through the p-JNK-NF-kappaB-TRPC6 pathway. Int J Mol Med. 2016;37(1):258–266. doi:10.3892/ijmm.2015.241926718129
   PubMed Web of Science ®Google Scholar
• Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999;6(2):99–104. doi:10.1038/sj.cdd.440047610200555
   PubMed Web of Science ®Google Scholar
• Jiang WB, Zhao W, Chen H, et al. Baicalin protects H9c2 cardiomyocytes against hypoxia/reoxygenation-induced apoptosis and oxidative stress through activation of mitochondrial aldehyde dehydrogenase 2. Clin Exp Pharmacol Physiol. 2017;45:3003–311.
   Web of Science ®Google Scholar
• Gao JM, Meng XW, Zhang J, et al. Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury by suppressing TLR4-MyD88-NF-kappaB signaling. Biomed Res Int. 2017;2017:1674613. doi:10.1155/2017/167461329359143
   PubMed Web of Science ®Google Scholar
• Ma LQ, Yu Y, Chen H, et al. Sweroside alleviated aconitine-induced cardiac toxicity in H9c2 cardiomyoblast cell line. Front Pharmacol. 2018;9:1138. doi:10.3389/fphar.2018.0113830410440
   PubMed Web of Science ®Google Scholar
• Ghasemi A, Zahediasl S. Normality tests for statistical analysis: a guide for non-statisticians. Int J Endocrinol Metab. 2012;10(2):486–489. doi:10.5812/ijem.350523843808
   PubMedGoogle Scholar
• Riquelme JA, Westermeier F, Hall AR, et al. Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism. Pharmacol Res. 2016;103:318–327. doi:10.1016/j.phrs.2015.11.00426607864
   PubMed Web of Science ®Google Scholar
• Yoshikawa Y, Hirata N, Kawaguchi R, Tokinaga Y, Yamakage M. Dexmedetomidine maintains its direct cardioprotective effect against ischemia/reperfusion injury in hypertensive hypertrophied myocardium. Anesth Analg. 2018;126(2):443–452. doi:10.1213/ANE.000000000000245228914648
   PubMed Web of Science ®Google Scholar
• Kristiansen SB, Haanes KA, Sheykhzade M, Edvinsson L. Endothelin receptor mediated Ca(2+) signaling in coronary arteries after experimentally induced ischemia/reperfusion injury in rat. J Mol Cell Cardiol. 2017;111:1–9. doi:10.1016/j.yjmcc.2017.07.01328757442
   PubMed Web of Science ®Google Scholar
• Akpinar H, Naziroglu M, Ovey IS, Cig B, Akpinar O. The neuroprotective action of dexmedetomidine on apoptosis, calcium entry and oxidative stress in cerebral ischemia-induced rats: contribution of TRPM2 and TRPV1 channels. Sci Rep. 2016;6:37196. doi:10.1038/srep3719627872485
   PubMed Web of Science ®Google Scholar
• Yang D, Hong JH. Dexmedetomidine modulates histamine-induced Ca(2+) signaling and pro-inflammatory cytokine expression. Korean J Physiol Pharmacol. 2015;19(5):413–420. doi:10.4196/kjpp.2015.19.5.41326330753
   PubMed Web of Science ®Google Scholar
• Zucchi R, Ronca F, Ronca-Testoni S. Modulation of sarcoplasmic reticulum function: a new strategy in cardioprotection? Pharmacol Ther. 2001;89(1):47–65. doi:10.1016/S0163-7258(00)00103-011316513
   PubMed Web of Science ®Google Scholar
• Fauconnier J, Meli AC, Thireau J, et al. Ryanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia-reperfusion. Proc Natl Acad Sci U S A. 2011;108(32):13258–13263. doi:10.1073/pnas.110028610821788490
   PubMed Web of Science ®Google Scholar
• Liao B, Zheng YM, Yadav VR, Korde AS, Wang YX. Hypoxia induces intracellular Ca2+ release by causing reactive oxygen species-mediated dissociation of FK506-binding protein 12.6 from ryanodine receptor 2 in pulmonary artery myocytes. Antioxid Redox Signal. 2011;14(1):37–47. doi:10.1089/ars.2009.304720518593
   PubMed Web of Science ®Google Scholar
• Wehrens XH, Lehnart SE, Marks AR. Intracellular calcium release and cardiac disease. Annu Rev Physiol. 2005;67:69–98. doi:10.1146/annurev.physiol.67.040403.11452115709953
   PubMed Web of Science ®Google Scholar
• Na T, Huang ZJ, Dai DZ, Zhang Y, Dai Y. Abrupt changes in FKBP12.6 and SERCA2a expression contribute to sudden occurrence of ventricular fibrillation on reperfusion and are prevented by CPU86017. Acta Pharmacol Sin. 2007;28(6):773–782. doi:10.1111/j.1745-7254.2007.00580.x17506935
   PubMed Web of Science ®Google Scholar
• McCall E, Li L, Satoh H, Shannon TR, Blatter LA, Bers DM. Effects of FK-506 on contraction and Ca2+ transients in rat cardiac myocytes. Circ Res. 1996;79(6):1110–1121. doi:10.1161/01.res.79.6.11108943949
   PubMed Web of Science ®Google Scholar
• Xin HB, Senbonmatsu T, Cheng DS, et al. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature. 2002;416(6878):334–338. doi:10.1038/416334a11907581
   PubMed Web of Science ®Google Scholar
• Wehrens XH, Lehnart SE, Huang F, et al. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell. 2003;113(7):829–840. doi:10.1016/s0092-8674(03)00434-312837242
   PubMed Web of Science ®Google Scholar
• Huang F, Shan J, Reiken S, Wehrens XH, Marks AR. Analysis of calstabin2 (FKBP12.6)-ryanodine receptor interactions: rescue of heart failure by calstabin2 in mice. Proc Natl Acad Sci U S A. 2006;103(9):3456–3461. doi:10.1073/pnas.051128210316481613
   PubMed Web of Science ®Google Scholar
• Tang J, Ge Y, Yang L, et al. ER stress via CHOP pathway is involved in FK506-induced apoptosis in rat fibroblasts. Cell Physiol Biochem. 2016;39(5):1965–1976. doi:10.1159/00044789427771715
   PubMedGoogle Scholar
• Yang J, Zhang R, Jiang X, et al. Toll-like receptor 4-induced ryanodine receptor 2 oxidation and sarcoplasmic reticulum Ca(2+) leakage promote cardiac contractile dysfunction in sepsis. J Biol Chem. 2018;293(3):794–807. doi:10.1074/jbc.M117.81228929150444
   PubMed Web of Science ®Google Scholar
• Chen BS, Peng H, Wu SN. Dexmedetomidine, an alpha2-adrenergic agonist, inhibits neuronal delayed-rectifier potassium current and sodium current. Br J Anaesth. 2009;103(2):244–254. doi:10.1093/bja/aep10719542547
   PubMed Web of Science ®Google Scholar
• Cai Y, Xu H, Yan J, Zhang L, Lu Y. Molecular targets and mechanism of action of dexmedetomidine in treatment of ischemia/reperfusion injury. Mol Med Rep. 2014;9(5):1542–1550. doi:10.3892/mmr.2014.203424627001
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhou CL, Xia ZY, Wang L. Effects of dexmedetomidine on L-type calcium current in rat ventricular myocytes. Acta Cardiologica Sinica. 2013;29(2):175–180.27122702
   PubMed Web of Science ®Google Scholar
• Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93(2):382–394. doi:10.1097/00000542-200008000-0001610910487
   PubMed Web of Science ®Google Scholar
• Peng K, Qiu Y, Li J, Zhang ZC, Ji FH. Dexmedetomidine attenuates hypoxia/reoxygenation injury in primary neonatal rat cardiomyocytes. Exp Ther Med. 2017;14(1):689–695. doi:10.3892/etm.2017.453728672986
   PubMed Web of Science ®Google Scholar
• Tan Y, Bi X, Wang Q, et al. Dexmedetomidine protects PC12 cells from lidocaine-induced cytotoxicity via downregulation of Stathmin 1. Drug Des Devel Ther. 2019;13:2067–2079. doi:10.2147/DDDT.S199572
   PubMed Web of Science ®Google Scholar
• Pan X, Zhang Z, Huang YY, Zhao J, Wang L. Electrophysiological effects of dexmedetomidine on sinoatrial nodes of rabbits. Acta Cardiologica Sinica. 2015;31(6):543–549.27122920
   PubMed Web of Science ®Google Scholar
• Kang SM, Lim S, Song H, et al. Allopurinol modulates reactive oxygen species generation and Ca2+ overload in ischemia-reperfused heart and hypoxia-reoxygenated cardiomyocytes. Eur J Pharmacol. 2006;535(1–3):212–219. doi:10.1016/j.ejphar.2006.01.01316516885
   PubMed Web of Science ®Google Scholar
• Wang R, Yang M, Wang M, et al. Total saponins of Aralia elata (Miq) seem alleviate calcium homeostasis imbalance and endoplasmic reticulum stress-related apoptosis induced by myocardial ischemia/reperfusion injury. Cell Physiol Biochem. 2018;50(1):28–40. doi:10.1159/00049395430278458
   PubMed Web of Science ®Google Scholar
• Zhang CM, Gao L, Zheng YJ, Yang HT. Berbamine protects the heart from ischemia/reperfusion injury by maintaining cytosolic Ca(2+) homeostasis and preventing calpain activation. Circ J. 2012;76(8):1993–2002. doi:10.1253/circj.cj-11-143122664727
   PubMed Web of Science ®Google Scholar